Sample repository from a longitudinal HIV clinical dataset containing patient demographics, CD4 counts, viral load measurements, treatment regimens, comorbidities, WHO staging, and clinical outcomes for healthcare analytics and research.
This dataset is a large-scale longitudinal HIV clinical outcomes repository designed to support healthcare analytics, clinical research, epidemiology, population health studies, real-world evidence generation, and healthcare AI applications.
The dataset contains over 579,000 patient records capturing longitudinal treatment journeys, clinical outcomes, laboratory measurements, treatment regimens, disease progression indicators, and patient demographics. The collection provides a comprehensive view of HIV care pathways and patient management over time.
The longitudinal nature of the dataset enables researchers and organizations to analyze treatment effectiveness, disease progression, patient outcomes, comorbidity patterns, and population-level healthcare trends.
Dataset Coverage
The dataset includes:
Patient demographic information
CD4 count measurements
Viral load measurements
Treatment regimen information
Comorbidity data
WHO clinical staging
Longitudinal outcome tracking
Patient progression records
Key Features
470,000+ patient records
Longitudinal healthcare data
HIV treatment history
Clinical outcomes information
Laboratory measurements
Population health insights
Real-world clinical data
Structured healthcare records
Applications
Healthcare Analytics
Clinical Outcomes Research
Epidemiological Studies
Population Health Analysis
Real-World Evidence (RWE)
Healthcare AI
Predictive Healthcare Modeling
Disease Progression Analysis
Treatment Effectiveness Studies
Clinical Research
Research Value
The dataset enables analysis of long-term patient outcomes, treatment adherence, disease progression, healthcare interventions, and population-level health trends. Researchers can leverage the data to study clinical effectiveness, healthcare delivery patterns, and outcome-based healthcare initiatives.
Healthcare Analytics
Organizations can use the dataset for longitudinal modeling, outcome prediction, patient risk stratification, treatment pathway analysis, healthcare planning, and public health research.
Licensing & Access
This listing contains sample data intended for research, evaluation, and educational purposes. Enterprise licensing and access to the complete dataset are available upon request.
579,000+ longitudinal patient records containing HIV treatment histories, CD4 counts, viral load measurements, and clinical outcomes.
Includes demographic information, treatment regimens, comorbidities, WHO staging, and patient progression data collected across longitudinal care pathways.
Designed for healthcare analytics, population health research, clinical outcomes analysis, epidemiological studies, and real-world evidence generation.
AWS Marketplace now accepts line of credit payments through the PNC Vendor Finance program. This program is available to select AWS customers in the US, excluding NV, NC, ND, TN, & VT.
This listing uses a single pricing dimension: Product Access (Units). You get access to the dataset through this one option, with no tiers, instance sizes, or usage add-ons to choose between. The product is offered at no cost, so there is no scaling by volume or term. The dataset covers de-identified longitudinal HIV clinical outcomes, including treatment timeline fields across time. Access is granted to subscribers under this single flat dimension.
Top-of-mind questions for buyers
What does one unit of Product Access grant me?
One unit grants subscriber access to the longitudinal HIV clinical outcomes dataset. It is a flat access grant, not a per-record or per-patient meter. Access covers the de-identified HIV ART fields, including CD4 values, viral load, regimen information, comorbidities, and WHO staging across time.
In what format is the HIV dataset delivered after I get access?
Healthcare data is delivered as DICOM files, PDF documents, and anonymised metadata. Patient identifiers are removed at the source, and data lineage documentation is available for compliance review. The dataset covers treatment timeline fields recorded across multiple points in time.
Can I review a sample before committing to the full dataset?
Yes. The vendor supports scoped sample requests so you can evaluate format, coverage, and suitability. Healthcare samples are available under NDA with institutional review. This lets you check fit before a larger engagement.
infobay.ai+1
Helpful?
Vendor refund policy
No Refund
How can we make this page better?
Tell us how we can improve this page, or report an issue with this product.
Give us feedbackReport a problem with this product or seller
Legal
Vendor terms and conditions
Upon subscribing to this product, you must acknowledge and agree to the terms and conditions outlined in the vendor's End User License Agreement (EULA).
Content disclaimer
Vendors are responsible for their product descriptions and other product content. AWS does not warrant that vendors' product descriptions or other product content are accurate, complete, reliable, current, or error-free.
Centers for Disease Control and Prevention provides free and open access to various health related data. This dataset contains behavioral data for HIV AIDS from 2011 to present. BRFSS (Behavioral Risk Factor Surveillance System) combined land line and cell phone prevalence data. BRFSS is a continuous, state-based surveillance system that collects information about modifiable risk factors for chronic diseases and other leading causes of death
Sample repository from a large-scale longitudinal time series dataset containing temporal sequences, event histories, behavioral patterns, and sequential records designed for forecasting, predictive analytics, machine learning, and AI applications.
The Relating Clinical Outcomes in Multiple Myeloma to Personal Assessment of Genetic Profile study is the Multiple Myeloma Research Foundation (MMRF)’s landmark personalized medicine initiative. CoMMpass is a
longitudinal observation study of around 1000 newly diagnosed myeloma patients receiving various
standard approved treatments. The MMRF’s vision is to track the treatment and results for each
CoMMpass patient so that someday the information can be used to guide decisions for newly
diagnosed patients. CoMMpass checked on patients every 6 months for 8 years, collecting tissue
samples, genetic, information, quality of life and various disease and clinical outcomes. The
study has produced one of the largest genomic and clinical datasets of a single disease.
The Cancer Genome Characterization Initiatives (CGCI) program supports cutting-edge genomics research of adult and pediatric cancers. CGCI investigators develop and apply advanced sequencing methods that examine genomes, exomes, and transcriptomes within various types of tumors. The program includes Burkitt Lymphoma Genome Sequencing Project (BLGSP) project and HIV+ Tumor Molecular Characterization Project - Cervical Cancer (HTMCP-CC) project.
The dataset contains open Clinical Supplement, Biospecimen Supplement, RNA-Seq Gene Expression Quantification, miRNA-Seq Isoform Expression Quantification, and miRNA Expression Quantification data.
This dataset also contains controlled WGS/Targeted Sequencing/RNA-Seq/miRNA-Seq Aligned Reads, and RNA-Seq Splice Junction Quantification